BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17683514)

  • 1. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.
    Takahashi S; Aiba K; Ito Y; Hatake K; Nakane M; Kobayashi T; Minowa S; Shibata H; Mitsuhashi J; Tsukahara S; Ishikawa E; Suzuki R; Tsuruo T; Sugimoto Y
    Cancer Sci; 2007 Oct; 98(10):1609-16. PubMed ID: 17683514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital.
    Takahashi S; Ito Y; Hatake K; Sugimoto Y
    Breast Cancer; 2006; 13(1):8-15. PubMed ID: 16518057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.
    Moscow JA; Huang H; Carter C; Hines K; Zujewski J; Cusack G; Chow C; Venzon D; Sorrentino B; Chiang Y; Goldspiel B; Leitman S; Read EJ; Abati A; Gottesman MM; Pastan I; Sellers S; Dunbar C; Cowan KH
    Blood; 1999 Jul; 94(1):52-61. PubMed ID: 10381498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.
    Mitsuhashi J; Tsukahara S; Suzuki R; Oh-hara Y; Nishi S; Hosoyama H; Katayama K; Noguchi K; Minowa S; Shibata H; Ito Y; Hatake K; Aiba K; Takahashi S; Sugimoto Y
    Hum Gene Ther; 2007 Oct; 18(10):895-906. PubMed ID: 17907967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy for breast cancer].
    Takahashi S; Hatake K; Sugimoto Y
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):468-77. PubMed ID: 12722676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.
    Hesdorffer C; Ayello J; Ward M; Kaubisch A; Vahdat L; Balmaceda C; Garrett T; Fetell M; Reiss R; Bank A; Antman K
    J Clin Oncol; 1998 Jan; 16(1):165-72. PubMed ID: 9440739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells.
    Salih SM
    Fertil Steril; 2011 Mar; 95(4):1390-6.e1-6. PubMed ID: 21316663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
    O'Shaughnessy JA; Cowan KH; Nienhuis AW; McDonagh KT; Sorrentino BP; Dunbar CE; Chiang Y; Wilson W; Goldspiel B; Kohler D
    Hum Gene Ther; 1994 Jul; 5(7):891-911. PubMed ID: 7526902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies.
    Hibino H; Tani K; Ikebuchi K; Wu MS; Sugiyama H; Nakazaki Y; Tanabe T; Takahashi S; Tojo A; Suzuki S; Tanioka Y; Sugimoto Y; Nakahata T; Asano S
    Blood; 1999 May; 93(9):2839-48. PubMed ID: 10216078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia.
    Machiels JP; Govaerts AS; Guillaume T; Bayat B; Feyens AM; Lenoir E; Goeminne JC; Cole S; Deeley R; Caruso M; Bank A; Symann M; D'Hondt V
    Hum Gene Ther; 1999 Mar; 10(5):801-11. PubMed ID: 10210147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection.
    Schwarzenberger P; Spence S; Lohrey N; Kmiecik T; Longo DL; Murphy WJ; Ruscetti FW; Keller JR
    Blood; 1996 Apr; 87(7):2723-31. PubMed ID: 8639888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.
    Carpinteiro A; Peinert S; Ostertag W; Zander AR; Hossfeld DK; Kühlcke K; Eckert HG; Baum C; Hegewisch-Becker S
    Int J Cancer; 2002 Apr; 98(5):785-92. PubMed ID: 11920652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture.
    Bunting KD; Galipeau J; Topham D; Benaim E; Sorrentino BP
    Ann N Y Acad Sci; 1999 Apr; 872():125-40; discussion 140-1. PubMed ID: 10372117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts.
    Kittler EL; Peters SO; Crittenden RB; Debatis ME; Ramshaw HS; Stewart FM; Quesenberry PJ
    Blood; 1997 Jul; 90(2):865-72. PubMed ID: 9226188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
    Guo C; Jin X
    Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection.
    Hegewisch-Becker S; Hanania EG; Fu S; Körbling M; Deisseroth AB; Andreeff M
    Br J Haematol; 1995 Aug; 90(4):876-83. PubMed ID: 7669666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate.
    Mitsuhashi J; Hosoyama H; Tsukahara S; Katayama K; Noguchi K; Ito Y; Hatake K; Aiba K; Takahashi S; Sugimoto Y
    J Gene Med; 2010 Jul; 12(7):596-603. PubMed ID: 20533531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.
    O'Shaughnessy JA; Cowan KH; Wilson W; Bryant G; Goldspiel B; Gress R; Nienhuis AW; Dunbar C; Sorrentino B; Stewart FM
    Hum Gene Ther; 1993 Jun; 4(3):331-54. PubMed ID: 8338880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.